Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Invitae Corp (NVTA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,189,443
  • Shares Outstanding, K 74,617
  • Annual Sales, $ 68,220 K
  • Annual Income, $ -123,380 K
  • 36-Month Beta 2.07
  • Price/Sales 7.67
  • Price/Cash Flow N/A
  • Price/Book 6.14

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/18
See More
  • Average Estimate -0.42
  • Number of Estimates 5
  • High Estimate -0.38
  • Low Estimate -0.47
  • Prior Year -0.78
  • Growth Rate Est. (year over year) +46.15%

Price Performance

See More
Period Period Low Period High Performance
1-Month
13.00 +23.54%
on 02/05/19
16.25 -1.17%
on 02/15/19
+1.76 (+12.31%)
since 01/15/19
3-Month
9.04 +77.65%
on 12/24/18
16.25 -1.17%
on 02/15/19
+3.16 (+24.50%)
since 11/15/18
52-Week
4.35 +269.20%
on 03/28/18
18.38 -12.60%
on 09/18/18
+9.87 (+159.45%)
since 02/15/18

Most Recent Stories

More News
Uptrend Call Working As Invitae Corp Stock Rises 19.6% (NVTA)

SmarTrend identified an Uptrend for Invitae Corp (NYSE:NVTA) on January 7th, 2019 at $13.09. In approximately 1 month, Invitae Corp has returned 19.56% as of today's recent price of $15.65.

NVTA : 16.06 (+0.75%)
Recent Analysis Shows General Mills, Paycom Software, Invitae, Jagged Peak Energy, John B. Sanfilippo & Son, and Intrepid Potash Market Influences -- Renewed Outlook, Key Drivers of Growth

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of General Mills, Inc. (NYSE:GIS),...

GIS : 45.04 (+1.15%)
NVTA : 16.06 (+0.75%)
JAG : 10.94 (+2.05%)
IPI : 3.81 (unch)
JBSS : 70.92 (+1.26%)
PAYC : 182.47 (+2.29%)
Invitae to Present at the 8th Annual SVB Leerink Global Healthcare Conference

Invitae Corporation (NYSE: NVTA), a leading genetics company, today announced that Sean George, co-founder and chief executive officer of Invitae, will present at the 8th Annual SVB Leerink Global Healthcare...

NVTA : 16.06 (+0.75%)
Invitae (NVTA) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

Invitae (NVTA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

NVTA : 16.06 (+0.75%)
Is the Options Market Predicting a Spike in Invitae (NVTA) Stock?

Investors need to pay close attention to Invitae (NVTA) stock based on the movements in the options market lately.

NVTA : 16.06 (+0.75%)
Invitae Launches Non-Invasive Prenatal Screening (NIPS), Offering In-Depth Genetic Information in Early Pregnancy

Invitae Corporation (NYSE: NVTA), a leading genetics company, today announced the addition of non-invasive prenatal screening (NIPS) to the company's comprehensive women's health genetic testing services,...

NVTA : 16.06 (+0.75%)
New Study Finds Disease-Causing Variants More Common in Men with Prostate Cancer Than Previously Thought

The largest study to date on the genetics of prostate cancer has found that 17 percent of prostate cancer patients are born with genetic variants that can be associated with higher risk of various cancers....

NVTA : 16.06 (+0.75%)
Invitae to announce fourth quarter and year-end 2018 financial results on February 19, 2019

Invitae Corporation (NYSE: NVTA), the fastest growing clinical genetics company, today announced that it will report its fourth quarter and year-end 2018 financial results on Tuesday, February 19, 2019...

NVTA : 16.06 (+0.75%)
Invitae Corp Shares Up 12.4% Since SmarTrend's Buy Recommendation (NVTA)

SmarTrend identified an Uptrend for Invitae Corp (NYSE:NVTA) on January 7th, 2019 at $13.09. In approximately 2 weeks, Invitae Corp has returned 12.38% as of today's recent price of $14.71.

NVTA : 16.06 (+0.75%)
Best Relative Performance in the Biotechnology Industry Detected in Shares of Blueprint Medici (BPMC , NVTA , CLVS , EXAS , ARRY )

Here are the top 5 stocks in the Biotechnology industry ranked by performance. We compiled the trading activity from yesterday and then analyzed the industry looking for stocks that were outperforming....

NVTA : 16.06 (+0.75%)
CLVS : 25.49 (+0.08%)
BPMC : 76.09 (+1.94%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators mostly agree with the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Trade NVTA with:

Business Summary

Invitae Corporation is engaged in genetic diagnostics for hereditary disorders which include breast, colon and pancreatic cancer. It operates primarily in the United States, Israel and internationally. Invitae Corporation is headquartered in San Francisco, California.

See More

Key Turning Points

2nd Resistance Point 16.72
1st Resistance Point 16.39
Last Price 16.06
1st Support Level 15.59
2nd Support Level 15.12

See More

52-Week High 18.38
Last Price 16.06
Fibonacci 61.8% 13.02
Fibonacci 50% 11.36
Fibonacci 38.2% 9.71
52-Week Low 4.35

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar